Doxazosin-structure.jpg (Doxazosin Structure)
Doxazosin
Product Images NDC 50090-2434
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-2434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1.jpg (Figure1)
Label Image (Lbl500902434)
Table3.jpg (Table3)
The text appears to be a summary of effectiveness data in placebo-controlled trials for doxazosin in treating patients with benign prostatic hyperplasia. The text shows the maximum flow rate, symptom score, baseline change, and mean values for both the placebo and doxazosin groups in three different studies. The studies lasted between 12 to 14 weeks and involved using various doses of doxazosin. The effectiveness of doxazosin was measured using the AUA questionnaire and Modified Boyarsky Questionnaire. No further context is given to interpret this data.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
